跳至主要内容
临床试验/NCT05579847
NCT05579847已完成不适用

The Feasibility of an Educational and Monitoring Smart-Phone Application for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy

H. Lee Moffitt Cancer Center and Research Institute1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年10月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Acceptability of Smart Phone Application

研究概览

简要总结

The purpose of the study is to test and understand acceptability and preliminary effectiveness of a mobile educational app specifically customized to patients with advanced Renal Cell Carcinoma (RCC) receiving therapy with combination immunotherapy.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with Stage IV Renal Cell Carcinoma
  • Within 3 weeks from starting combination immune checkpoint blockade with tyrosine kinase inhibitor or multikinase inhibitor
  • Estimated survival of 6 months or more
  • Able to read and speak English

排除标准

  • Unable to read or speak English
  • Enrolled in another clinical trial

结局指标

主要结局

Acceptability of Smart Phone Application

时间窗: at 6 months

Patient's acceptability of the smart phone application for education will be captured in the patient post education survey.

次要结局

  • Efficacy of Smart Phone Application -Quality of Life(at 6 months)
  • Efficacy of Smart Phone Application - Patient Knowledge(Weekly, beginning at baseline to month 6)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验